Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Lymphoid × sargramostim × 1 year × Clear all

Sponsor

Conditions

Neuroblastoma 10 Melanoma 4 Ganglioneuroblastoma 4 Triple Negative Breast Neoplasms 3 Lung Neoplasms 3 Carcinoma, Non-Small-Cell Lung 2 Adenoma, Islet Cell 2 Wilms Tumor 1 Uveal Melanoma 1 Uterine Cervical Neoplasms 1 Transplant-Related Hematologic Malignancy 1 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma, Alveolar Soft Part 1 Recurrence 1 Prostatic Neoplasms 1 Pathologic Complete Response 1 Neoplasms 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Mesothelioma, Malignant 1 Mesothelioma 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma 1 Locally Advanced Pancreatic Adenocarcinoma 1 Leukemia, Plasma Cell 1 Leukemia, Myeloid, Acute 1 Leukemia 1 Hodgkin Disease 1 Gliosarcoma 1 Glioblastoma 1

Interventions

Cyclophosphamide 7 fludarabine phosphate 5 fludarabine 4 Whole-Body Irradiation 4 Tacrolimus 4 Peripheral Blood Stem Cell Transplantation 4 Mycophenolic Acid 3 Mesna 3 Busulfan 3 pirtobrutinib 2 ibrutinib 2 Patient Reported Outcome Measures 2 Melphalan 2 Bone Marrow Transplantation 2 Biopsy 2 venetoclax 1 pembrolizumab 1 pegylated granulocyte colony-stimulating factor 1 duvelisib 1 Thiotepa 1 Surveys and Questionnaires 1 Social Determinants of Health 1 Sirolimus 1 Receptors, Chimeric Antigen 1 Methotrexate 1 Leukapheresis 1 Immunotherapy, Adoptive 1 Cyclosporins 1 Cyclosporine 1 Azacitidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡